Presentation TCT 2025 TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal Presenter: Mohammed Ebrahim October 27, 2025
Presentation TCT 2025 TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy Presenter: Mehmet Cilingiroglu October 27, 2025
Presentation TCT 2025 TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial Presenter: Devi G. Nair October 27, 2025
Presentation TCT 2025 In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation?? Presenter: Suhail Dohad October 27, 2025
Presentation TCT 2025 TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis. Presenter: Kanishk Aggarwal October 27, 2025
Presentation TCT 2025 Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure Presenter: Josep Rodés-Cabau October 26, 2025
Presentation TCT 2025 Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE Presenter: Robert A. Lookstein October 26, 2025
Presentation TCT 2025 TCT 1929: A Case of Trombectomy in Pulmonary Embolism With Absolute Contraindication to Anticoagulation Presenter: Mario Iannaccone October 26, 2025
Presentation TCT 2025 Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study Presenter: Grant William Reed October 25, 2025
Presentation TCT 2025 TCT 1369: When Watchman Isn’t Watched Enough: Rare Persistent Late Device Thrombus Despite Anticoagulation Presenter: Ammer Aldairi October 25, 2025
Presentation ESC 2025 AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation Presenter: Martine Gilard August 30, 2025
Presentation NY Valves 2025 Management of HALT After TAVR: Anticoagulation, Which Agent, How Long Presenter: George D. Dangas June 26, 2025
Presentation AHA 2024 Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation Presenter: Oussama M. Wazni November 16, 2024
Presentation TCT 2024 TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation Presenter: Daniel Overduin October 30, 2024
Presentation TCT 2024 TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life Presenter: Dirk Jan van Ginkel October 29, 2024
Presentation TCT 2024 TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement Presenter: Koki Takegawa October 29, 2024
Presentation TCT 2024 How to Deal With Large Leaks: Anticoagulation, Leak Closure or Extract and Replace the Device? Presenter: Rodney Horton October 28, 2024
Presentation TCT 2024 TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis Presenter: Ahmed Younes October 27, 2024
Presentation TCT 2024 TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs Presenter: Sheref Elseidy October 27, 2024
Presentation TCT 2024 TCT 188: Inpatient Outcomes of Transcatheter Aortic Valve Replacement Patients on Chronic Anticoagulation: A Nationwide Analysis Presenter: Ibrahim Kamel October 27, 2024